pharma · Chronic Spontaneous Urticaria (CSU) · Asthma · SPRY
Ars Pharmaceuticals Irl
Ars Pharmaceuticals Irl Limited
Ars Pharmaceuticals Irl is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker SPRY. Primary therapeutic focus areas include Chronic Spontaneous Urticaria (CSU), Asthma, Urticaria, Upper
San Diego, USA HQ
187 Employees
Public company Type
SPRY · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Employees
- 187
- Programs
- 8
- Drugs
- 7
- Patents
- 0
IXCHIQ
Approved · mab · Chikungunya Virus Infection
IXCHIQ for Chikungunya Virus Infection is a Approved program (mab) at Ars Pharmaceuticals Irl Limited with 1 ClinicalTrials.gov record(s).
Internal code 2025/CHU/12
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ars Pharmaceuticals Irl Limited
- Phase
- Approved
- Modality
- mab
- Indication
- Chikungunya Virus Infection
- Status
- active
- Trials
- 1